KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Total Non-Current Liabilities (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Total Non-Current Liabilities for 7 consecutive years, with $779.1 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 18.64% to $779.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $779.1 million through Dec 2025, up 18.64% year-over-year, with the annual reading at $779.1 million for FY2025, 18.64% up from the prior year.
  • Total Non-Current Liabilities hit $779.1 million in Q4 2025 for GoodRx Holdings, up from $717.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $818.9 million in Q3 2023 to a low of $634.0 million in Q1 2025.
  • Historically, Total Non-Current Liabilities has averaged $751.5 million across 5 years, with a median of $769.0 million in 2021.
  • Biggest YoY gain for Total Non-Current Liabilities was 18.64% in 2025; the steepest drop was 22.16% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $770.6 million in 2021, then increased by 1.52% to $782.2 million in 2022, then rose by 4.66% to $818.7 million in 2023, then fell by 19.79% to $656.7 million in 2024, then rose by 18.64% to $779.1 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for GDRX at $779.1 million in Q4 2025, $717.2 million in Q3 2025, and $668.6 million in Q2 2025.